Skip to content

Clinical trials

Mood Disorders trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20141
20151
20221
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Enrolling by invitation2
Recruiting2
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Korea University Anam Hospital3
Eli Lilly and Company2
Takeda2
H. Lundbeck A/S1
Hallym University Medical Center1
Hanyang University1
Hyung Keun Park1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sanofi1
Wonkwang University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders14
Major Depressive Disorder8
Depressive Disorder7
Bipolar Disorder4
Mental Disorders4
Affective Disorders, Psychotic1
Dysthymic Disorder1
Mania1

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.